Category: Providers

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

January 30, 2024 Rich Daly, Editor in Chief Views

Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.

The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospitals Had Largest Markups of High-Cost Infused Drugs: Study

January 30, 2024 Rich Daly, Editor in Chief Views

A New England Journal of Medicine study found that 340B hospitals had larger price markups than other hospitals or physician practices for certain high-cost infusion drugs.

340B hospitals had larger price markups than other hospitals or physician practices for 57 high-cost infusion drugs, according to a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK, Vertex Offer Refunds to 340B Providers

January 30, 2024 Rich Daly, Editor in Chief Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genesis CEO Praises Court Decision, Blasts HRSA, NACHC, State Primary Care Association

January 25, 2024 Rich Daly, Editor in Chief Views

Tony Megna, CEO and general counsel of Genesis Healthcare, shared his first public comments with 340B Report on a key 340B court decision.

In his first public comments since a key federal court decision on the 340B patient definition, the leader of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arkansas Looks to Amend Temporary Contract Pharmacy Agreement with Novo Nordisk

January 25, 2024 Rich Daly, Editor in Chief Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

After hospitals in Arkansas raised concerns over details of an agreement by Novo Nordisk to temporarily loosen contract pharmacy restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Arizona State Senators Introduce Latest 340B Contract Pharmacy Bill

January 25, 2024 William Newton, Associate Editor/Senior Writer Views

Two influential Arizona state senators recently introduced a bill that would prohibit drugmaker restrictions on 340B contract pharmacy use.

Two high-ranking Republican Arizona state senators have introduced a bill that would bar drug manufacturer restrictions on 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HIV/AIDS Group Continues Legal Fight with Apexus Over 340B Prime Vendor Contract

January 25, 2024 William Newton, Associate Editor/Senior Writer Views

AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.

The AIDS Healthcare Foundation (AHF) recently urged a federal appeals court to reverse a lower court’s decision to dismiss its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provider-Drugmaker Lobbying Group Adds Two More Manufacturers

January 23, 2024 Rich Daly, Editor in Chief Views

340B Working Table's lobbying disclosure filing.

A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’

January 23, 2024 Rich Daly, Editor in Chief Views

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.

A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

January 23, 2024 William Newton, Associate Editor/Senior Writer Views

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.

A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live